United States of America
Price range: $15.00 through $30.00
Semax is a synthetic heptapeptide derived from ACTH, developed for neuroprotection and cognitive enhancement.
Semax is a synthetic peptide composed of seven amino acids (Met–Glu–His–Phe–Pro–Gly–Pro), designed as an analog of the ACTH (4–10) fragment with a stabilizing Pro–Gly–Pro tail to increase its metabolic stability and duration of action without triggering cortisol release. Unlike full-length ACTH, Semax retains neurotrophic effects while avoiding endocrine effects, making it primarily a nootropic and neuroprotective agent.
Mechanism of Action
Semax works mainly in the central nervous system. Its key mechanisms include:
Upregulation of brain-derived neurotrophic factor (BDNF) and activation of its TrkB receptor, supporting neuron survival, neuroplasticity, and memory formation.
Modulation of neurotransmitters, including dopamine and serotonin, which can influence mood, attention, and cognitive function.
Neuroprotection against oxidative stress and ischemic damage, which is particularly relevant in stroke and traumatic brain injury.
Gene expression modulation, affecting immune response and neural repair processes.
Clinical Uses
Semax has been approved in Russia for medical use and is listed on the Russian List of Vital & Essential Drugs. Its clinical applications include:
Ischemic stroke recovery and transient ischemic attacks
Cognitive impairment following head injury or neurological conditions
Optic nerve pathologies and attention/anxiety disorders
Neurorestorative support in rehabilitation after brain injuries
Most clinical evidence comes from Russian hospitals, where Semax has shown improved neurological recovery, better functional outcomes, and lower mortality when added to standard stroke protocols.
Safety and Regulatory Status
Semax appears to have a favorable safety profile, with no major adverse effects, addiction potential, or withdrawal syndrome reported in the literature. However, it is not approved by the FDA or EMA, and its use outside Russia is largely limited to research or biohacking contexts. U.S. regulators have raised concerns about compounding and safety due to limited human data.
Summary
Semax is a specialized neuropeptide designed for cognitive enhancement and neuroprotection. Its unique design allows it to mimic ACTH’s neurotrophic effects without hormonal side effects, making it a valuable tool in stroke recovery, brain injury rehabilitation, and nootropic applications. While widely used in Russia, it remains investigational in most other countries, with ongoing interest from researchers and biohackers
Reviews
There are no reviews yet.